SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-23-016293
Filing Date
2023-05-11
Accepted
2023-05-11 08:30:51
Documents
65
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1039184
2 ex31-1.htm EX-31.1 17095
3 ex31-2.htm EX-31.2 16831
4 ex32-1.htm EX-32.1 5006
5 ex32-2.htm EX-32.2 4759
6 form10-q_001.jpg GRAPHIC 93033
7 form10-q_002.jpg GRAPHIC 64661
  Complete submission text file 0001493152-23-016293.txt   5419454

Data Files

Seq Description Document Type Size
8 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lpcn-20230331.xsd EX-101.SCH 36913
9 INLINE XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT lpcn-20230331_cal.xml EX-101.CAL 47553
10 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lpcn-20230331_def.xml EX-101.DEF 166143
11 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lpcn-20230331_lab.xml EX-101.LAB 333199
12 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lpcn-20230331_pre.xml EX-101.PRE 261841
59 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 693876
Mailing Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108
Business Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108 801 994 7383
Lipocine Inc. (Filer) CIK: 0001535955 (see all company filings)

IRS No.: 990370688 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36357 | Film No.: 23909008
SIC: 2834 Pharmaceutical Preparations